Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine versus butorphanol for suppression of sufentanil-induced cough during general anesthesia induction
ChiCTR-IPR-17014201Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Harbin Medical University
- Start
- Dec 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dezocine, butorphanol and sufentanil in cough (3 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Cough times. Started Dec 2017; status: recruiting.
02
Drugs
dezocinebutorphanolsufentanil
03
Conditions
cough
Beyond the preview
Go deeper on ChiCTR-IPR-17014201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17014201.